Clinical trial
The Effect of the Braden Pressure Ulcer Scale on the Prediction of Intensive Care Unit Length of Stay
NCT06697340 is registered in ClinicalTrials.gov with Ankara City Hospital Bilkent as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of the Braden Pressure Ulcer Scale on the Prediction of Intensive Care Unit Length of Stay
- Lead sponsor
- Ankara City Hospital Bilkent
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 1, 2025
- Completion date
- May 31, 2025
- Enrollment
- 11,000 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
intensive care unit icu, length of icu stay, pressure ulcer risk, scale reliability validity